It is indicated that RBP4 concentrations are elevated in insulin-resistant mice and humans with obesity and diabetes and can be normalized by insulin-sensitizing drugs [10]. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.